| Agranulocytosis due to secondary exposure to antithyroid drugs in a relapsed Graves' disease patient |
|
Gwi Hong Jeong, Seong Kyun Kim, Dae Seong Myung, Jin Ook Chung, Dong Hyeok Cho, Dong Jin Chung, Min Young Chung |
|
경희대학교 의과대학 순환기내과학교실 |
| 증례: 재발된 그레이브스병 환자에서 항갑상샘약제 재투여 후 발생한 무과립구증 1예 |
|
정귀홍&#;김성균&#;명대성&#;정진욱&#;조동혁&#;정동진&#;정민영, Seong Kyun Kim, Dae Seong Myung, Jin Ook Chung, Dong Hyeok Cho, Dong Jin Chung, Min Young Chung |
|
|
|
|
|
|
| Abstract |
|
Antithyroid drugs are the most common treatment modality for Graves' disease and are used for the treatment of relapsed Graves' disease in Korea. Agranulocytosis is a rare and severe complication of antithyroid drug therapy, and most cases occur within 3 month after drug treatment. Agranulocytosis can develop in patients who have relapsed Graves' disease and undergo a second course of antithyroid drugs with a prior uneventful course of drug therapy.
We report a case of antithyroid drug-induced agranulocytosis in a relapsed Graves' disease patient who had undergone prior uneventful antithyroid drug therapy. We also present a review of the relevant literature. (Korean J Med 75:362-366, 2008) |
| Key Words:
Graves' Disease; Recurrence; Antithyroid agents; Agranulocytosis |
|
PDF Links
Full text via DOI
Download Citation
